iCAD, Inc. (ICAD)
NASDAQ: ICAD · IEX Real-Time Price · USD
1.470
-0.010 (-0.68%)
At close: Apr 26, 2024, 4:00 PM
1.460
-0.010 (-0.68%)
After-hours: Apr 26, 2024, 4:02 PM EDT
iCAD, Inc. Market Cap
iCAD, Inc. has a market cap or net worth of $39.01 million as of April 26, 2024. Its market cap has increased by 4.88% in one year.
Market Cap
39.01M
Enterprise Value
17.80M
1-Year Change
4.88%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since December 1, 1998, iCAD, Inc.'s market cap has increased from $12.80M to $39.01M, an increase of 204.80%. That is a compound annual growth rate of 4.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 39.00M | -5.11% |
Apr 24, 2024 | 41.10M | - |
Apr 23, 2024 | 41.10M | 2.49% |
Apr 22, 2024 | 40.10M | -1.23% |
Apr 19, 2024 | 40.60M | -3.10% |
Apr 18, 2024 | 41.90M | 1.95% |
Apr 17, 2024 | 41.10M | -2.61% |
Apr 16, 2024 | 42.20M | -1.86% |
Apr 15, 2024 | 43.00M | -3.37% |
Apr 12, 2024 | 44.50M | -0.67% |
Apr 11, 2024 | 44.80M | -0.67% |
Apr 10, 2024 | 45.10M | -4.85% |
Apr 9, 2024 | 47.40M | 10.23% |
Apr 8, 2024 | 43.00M | 1.42% |
Apr 5, 2024 | 42.40M | -1.40% |
Apr 4, 2024 | 43.00M | -14.17% |
Apr 3, 2024 | 50.10M | 18.72% |
Apr 2, 2024 | 42.20M | 5.24% |
Apr 1, 2024 | 40.10M | -5.42% |
Mar 28, 2024 | 42.40M | 0.47% |
Mar 27, 2024 | 42.20M | 1.69% |
Mar 26, 2024 | 41.50M | 1.72% |
Mar 25, 2024 | 40.80M | -3.32% |
Mar 22, 2024 | 42.20M | - |
Mar 21, 2024 | 42.20M | 3.43% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Carmell Therapeutics | 42.34M |
Bolt Biotherapeutics | 42.32M |
NKGen Biotech | 42.19M |
Aspira Women's Health | 41.85M |
ReWalk Robotics | 41.55M |
SAB Biotherapeutics | 40.22M |
Rapid Micro Biosystems | 39.75M |
Marker Therapeutics | 39.40M |